Client News

Abivax Announces Launch of Public Offering of American Depositary Shares

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

smartbax secures additional financing to advance lead antibiotic program to IND filing

Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe

Darwin AG Announces Results of the 2026 Annual General Meeting

MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b

Finalists for the 2026 Strüngmann Award Announced: Award Recognizes Entrepreneurial Excellence and Significant Innovation Potential in Life Sciences

AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026